4.2 nSTEMI guidelines:
Patients diagnosed with an nSTEMI are immediately offered pharmaceutical
intervention (aspirin, heparin, fondaparinux or antithrombin) and
stratified into low, medium or high-risk groups using an established
scoring system such as the GRACE score.[32] The
GRACE score estimates the admission to 6 month mortality based on age,
blood pressure, creatinine levels as well as other
criteria.[36] Patients with low risk are managed
conservatively with continued monitoring. Intermediate and higher risk
patients are offered clopidogrel and assessed for reperfusion surgery
and given a SYNTAX score. Similar to the management of STEMI, PPCI is
the favoured option for reperfusion in the vast majority of patients.
CABG is only preferred when PCI is contraindicated in patients with a
high SYNTAX score.[37]